Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Influenza Vaccination market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Influenza Vaccination market. Detailed analysis of key players, along with key growth strategies adopted by Influenza Vaccination industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZeneca (Europe)
DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
Abbott (US)
Sanofi (Europe)
F Hoffmann-La Roche Ltd (Europe)
GlaxoSmithKline plc (Europe)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
BioCryst Pharmaceuticals, Inc (US)
Hualan Biological Engineering Inc (Asia Pacific)
Novartis AG (Europe)
By Type:
Egg Based
Cell Culture
Recombinant
By End-User:
Hospitals
Research Organizations
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccination Market
-
1.3 Market Segment by Type
-
1.3.1 USA Influenza Vaccination Market Size and Growth Rate of Egg Based from 2016 to 2027
-
1.3.2 USA Influenza Vaccination Market Size and Growth Rate of Cell Culture from 2016 to 2027
-
1.3.3 USA Influenza Vaccination Market Size and Growth Rate of Recombinant from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Influenza Vaccination Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Influenza Vaccination Market Size and Growth Rate of Research Organizations from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Influenza Vaccination Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Influenza Vaccination by Major Types
-
3.4.1 Market Size and Growth Rate of Egg Based
-
3.4.2 Market Size and Growth Rate of Cell Culture
-
3.4.3 Market Size and Growth Rate of Recombinant
4 Segmentation of Influenza Vaccination Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Influenza Vaccination by Major End-Users
-
4.4.1 Market Size and Growth Rate of Influenza Vaccination in Hospitals
-
4.4.2 Market Size and Growth Rate of Influenza Vaccination in Research Organizations
5 Market Analysis by Regions
-
5.1 USA Influenza Vaccination Production Analysis by Regions
-
5.2 USA Influenza Vaccination Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Influenza Vaccination Landscape Analysis
-
6.1 West USA Influenza Vaccination Landscape Analysis by Major Types
-
6.2 West USA Influenza Vaccination Landscape Analysis by Major End-Users
7 South USA Influenza Vaccination Landscape Analysis
-
7.1 South USA Influenza Vaccination Landscape Analysis by Major Types
-
7.2 South USA Influenza Vaccination Landscape Analysis by Major End-Users
8 Middle West USA Influenza Vaccination Landscape Analysis
-
8.1 Middle West USA Influenza Vaccination Landscape Analysis by Major Types
-
8.2 Middle West USA Influenza Vaccination Landscape Analysis by Major End-Users
9 Northeast USA Influenza Vaccination Landscape Analysis
-
9.1 Northeast USA Influenza Vaccination Landscape Analysis by Major Types
-
9.2 Northeast USA Influenza Vaccination Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 AstraZeneca (Europe)
-
10.1.1 AstraZeneca (Europe) Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
10.2.1 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Abbott (US)
-
10.3.1 Abbott (US) Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Sanofi (Europe)
-
10.4.1 Sanofi (Europe) Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 F Hoffmann-La Roche Ltd (Europe)
-
10.5.1 F Hoffmann-La Roche Ltd (Europe) Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 GlaxoSmithKline plc (Europe)
-
10.6.1 GlaxoSmithKline plc (Europe) Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
10.7.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 BioCryst Pharmaceuticals, Inc (US)
-
10.8.1 BioCryst Pharmaceuticals, Inc (US) Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Hualan Biological Engineering Inc (Asia Pacific)
-
10.9.1 Hualan Biological Engineering Inc (Asia Pacific) Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Novartis AG (Europe)
-
10.10.1 Novartis AG (Europe) Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Influenza Vaccination Market Size and Growth Rate of Egg Based from 2016 to 2027
-
Figure USA Influenza Vaccination Market Size and Growth Rate of Cell Culture from 2016 to 2027
-
Figure USA Influenza Vaccination Market Size and Growth Rate of Recombinant from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Influenza Vaccination Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Influenza Vaccination Market Size and Growth Rate of Research Organizations from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Influenza Vaccination Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Influenza Vaccination Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Influenza Vaccination
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Influenza Vaccination by Different Types from 2016 to 2027
-
Table Consumption Share of Influenza Vaccination by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Egg Based
-
Figure Market Size and Growth Rate of Cell Culture
-
Figure Market Size and Growth Rate of Recombinant
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Influenza Vaccination by Different End-Users from 2016 to 2027
-
Table Consumption Share of Influenza Vaccination by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Research Organizations
-
Table USA Influenza Vaccination Production by Regions
-
Table USA Influenza Vaccination Production Share by Regions
-
Figure USA Influenza Vaccination Production Share by Regions in 2016
-
Figure USA Influenza Vaccination Production Share by Regions in 2021
-
Figure USA Influenza Vaccination Production Share by Regions in 2027
-
Table USA Influenza Vaccination Consumption by Regions
-
Table USA Influenza Vaccination Consumption Share by Regions
-
Figure USA Influenza Vaccination Consumption Share by Regions in 2016
-
Figure USA Influenza Vaccination Consumption Share by Regions in 2021
-
Figure USA Influenza Vaccination Consumption Share by Regions in 2027
-
Table West USA Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table West USA Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure West USA Influenza Vaccination Consumption Share by Types in 2016
-
Figure West USA Influenza Vaccination Consumption Share by Types in 2021
-
Figure West USA Influenza Vaccination Consumption Share by Types in 2027
-
Table West USA Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table West USA Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure West USA Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure West USA Influenza Vaccination Consumption Share by End-Users in 2027
-
Table South USA Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table South USA Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure South USA Influenza Vaccination Consumption Share by Types in 2016
-
Figure South USA Influenza Vaccination Consumption Share by Types in 2021
-
Figure South USA Influenza Vaccination Consumption Share by Types in 2027
-
Table South USA Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table South USA Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure South USA Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure South USA Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Middle West USA Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table Middle West USA Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Influenza Vaccination Consumption Share by Types in 2016
-
Figure Middle West USA Influenza Vaccination Consumption Share by Types in 2021
-
Figure Middle West USA Influenza Vaccination Consumption Share by Types in 2027
-
Table Middle West USA Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure Middle West USA Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure Middle West USA Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Northeast USA Influenza Vaccination Consumption by Types from 2016 to 2027
-
Table Northeast USA Influenza Vaccination Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Influenza Vaccination Consumption Share by Types in 2016
-
Figure Northeast USA Influenza Vaccination Consumption Share by Types in 2021
-
Figure Northeast USA Influenza Vaccination Consumption Share by Types in 2027
-
Table Northeast USA Influenza Vaccination Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Influenza Vaccination Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Influenza Vaccination Consumption Share by End-Users in 2016
-
Figure Northeast USA Influenza Vaccination Consumption Share by End-Users in 2021
-
Figure Northeast USA Influenza Vaccination Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZeneca (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca (Europe)
-
Figure Sales and Growth Rate Analysis of AstraZeneca (Europe)
-
Figure Revenue and Market Share Analysis of AstraZeneca (Europe)
-
Table Product and Service Introduction of AstraZeneca (Europe)
-
Table Company Profile and Development Status of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Figure Sales and Growth Rate Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Figure Revenue and Market Share Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Table Product and Service Introduction of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)
-
Table Company Profile and Development Status of Abbott (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott (US)
-
Figure Sales and Growth Rate Analysis of Abbott (US)
-
Figure Revenue and Market Share Analysis of Abbott (US)
-
Table Product and Service Introduction of Abbott (US)
-
Table Company Profile and Development Status of Sanofi (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi (Europe)
-
Figure Sales and Growth Rate Analysis of Sanofi (Europe)
-
Figure Revenue and Market Share Analysis of Sanofi (Europe)
-
Table Product and Service Introduction of Sanofi (Europe)
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd (Europe)
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd (Europe)
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd (Europe)
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd (Europe)
-
Table Company Profile and Development Status of GlaxoSmithKline plc (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc (Europe)
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc (Europe)
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc (Europe)
-
Table Product and Service Introduction of GlaxoSmithKline plc (Europe)
-
Table Company Profile and Development Status of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Table Product and Service Introduction of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
-
Table Company Profile and Development Status of BioCryst Pharmaceuticals, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals, Inc (US)
-
Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals, Inc (US)
-
Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals, Inc (US)
-
Table Product and Service Introduction of BioCryst Pharmaceuticals, Inc (US)
-
Table Company Profile and Development Status of Hualan Biological Engineering Inc (Asia Pacific)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering Inc (Asia Pacific)
-
Figure Sales and Growth Rate Analysis of Hualan Biological Engineering Inc (Asia Pacific)
-
Figure Revenue and Market Share Analysis of Hualan Biological Engineering Inc (Asia Pacific)
-
Table Product and Service Introduction of Hualan Biological Engineering Inc (Asia Pacific)
-
Table Company Profile and Development Status of Novartis AG (Europe)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Europe)
-
Figure Sales and Growth Rate Analysis of Novartis AG (Europe)
-
Figure Revenue and Market Share Analysis of Novartis AG (Europe)
-
Table Product and Service Introduction of Novartis AG (Europe)
-
